Johnson & Johnson

General ticker "JNJ" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $392.5B (TTM average)

Johnson & Johnson follows the US Stock Market performance with the rate: 40.3%.

Estimated limits based on current volatility of 0.7%: low 203.12$, high 205.82$

Factors to consider:

  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2025-08-26, amount 1.30$ (Y2.57%)
  • Total employees count: 139800 as of 2024
  • Top business risk factors: Geopolitical risks, Litigation risks, Product liability, Intellectual property risks, Supply chain disruptions
  • Current price 17.4% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-29 to 2026-12-29

  • 2024-12-29 to 2025-12-29 estimated range: [120.43$, 172.49$]
  • 2025-12-29 to 2026-12-29 estimated range: [126.14$, 179.24$]

Financial Metrics affecting the JNJ estimates:

  • Negative: with PPE of 14.5 at the end of fiscal year the price was very high
  • Positive: Operating profit margin, % of 24.94 > 18.64
  • Positive: 6.82 < Operating cash flow per share per price, % of 6.95
  • Positive: Inventory ratio change, % of 0.68 <= 0.84
  • Negative: 0.01 < Interest expense per share per price, % of 0.22
  • Positive: -14.38 < Investing cash flow per share per price, % of -5.33
  • Positive: 18.93 < Shareholder equity ratio, % of 39.69 <= 41.86
  • Positive: Return on assets ratio (scaled to [-100,100]) of 7.24 > 6.04
  • Positive: Industry earnings per price (median), % of 5.01 > 4.43
  • Positive: Industry inventory ratio change (median), % of -2.14 <= -0.15

Similar symbols

Short-term JNJ quotes

Long-term JNJ plot with estimates

Financial data

YTD 2023-12-31 2024-12-29
Operating Revenue $85,159.00MM $88,821.00MM
Operating Expenses $61,750.00MM $66,672.00MM
Operating Income $23,409.00MM $22,149.00MM
Non-Operating Income $-8,347.00MM $-5,462.00MM
Interest Expense $772.00MM $755.00MM
R&D Expense $15,085.00MM $17,232.00MM
Income(Loss) $15,062.00MM $16,687.00MM
Taxes $1,736.00MM $2,621.00MM
Other Income(Loss) $21,827.00MM $0.00MM
Profit(Loss)* $56,980.00MM $14,066.00MM
Stockholders Equity $68,774.00MM $71,490.00MM
Inventory $11,181.00MM $12,444.00MM
Assets $167,558.00MM $180,104.00MM
Operating Cash Flow $22,791.00MM $24,266.00MM
Capital expenditure $4,543.00MM $4,424.00MM
Investing Cash Flow $878.00MM $-18,599.00MM
Financing Cash Flow $-15,825.00MM $-3,132.00MM
Earnings Per Share** $22.49 $5.84

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.